Chemistry Nobel Honours Work on Mirror-Image Molecules

The 2026 Chemistry Nobel has gone to a pair of chemists whose work solved a puzzle that troubled scientists for more than a century: why does life favour one mirror-image form of certain molecules over the other? Henri B. Kagan, a French chemist at Université Paris-Sud, and Kenso Soai, a Japanese chemist at the Tokyo University of Science, will share the prize "for the discovery of non-linear effects and autocatalysis in asymmetric organic synthesis," according to the Royal Swedish Academy of Sciences.

The Academy announced the Chemistry Nobel in Stockholm on 7 October. In a statement, it said the two researchers had found a solution to the mystery of how chemical asymmetry could emerge in the first place. Many molecules, including the amino acids that build proteins, exist in two versions that are mirror images of each other, much like left and right hands. Yet living organisms use almost exclusively one of those two forms. For a long time chemists wondered how that one-sided preference, which scientists call homochirality, could arise at all.

The work that changed how medicines are made

Kagan's contribution came from studying catalysts, the substances that speed up chemical reactions. In 1986 he noticed something that broke the expected rules: when he started a reaction with only a tiny excess of one mirror-image form, the product ended up containing a far larger excess than anyone thought possible. This "non-linear effect" meant chemists could steer reactions toward producing just one of the two mirror images far more reliably than before. It gave drug researchers a much better way to build molecules with exactly the shape their biological targets require, and it is one of the two discoveries named in this year's Chemistry Nobel.

Soai went one step further. He designed the first chemical reaction in which only one of the two potential mirror images was formed at all. The Nobel committee noted that, other than life itself, no one had ever achieved this feat, and described his experiment as one of the most spectacular in the history of chemistry. In the Soai reaction, a small initial imbalance amplifies itself: the product acts as its own catalyst, copying the winning mirror image again and again until it takes over the mixture. That autocatalysis is the second breakthrough recognised by the Chemistry Nobel.

Getting the handedness right is not an academic detail. A molecule and its mirror image can behave very differently inside the human body. One version of a drug can treat an illness while the other does nothing or causes harm. The most notorious example is thalidomide, a drug taken in the late 1950s and early 1960s whose mirror-image form caused severe birth defects. Modern medicine depends on making the correct version and the correct version only, and the methods pioneered by the Chemistry Nobel laureates made that kind of control possible at industrial scale. That precision now runs through drug discovery, from new diabetes treatments to brain-cancer drugs engineered to cross the blood-brain barrier.

Why a century-old question still mattered

Scientists have known about molecular handedness since Louis Pasteur first spotted it in crystals in 1848. What they could not explain was the leap from a world with no preference to a living one that shows such a strong one. Laboratory experiments kept producing equal amounts of both mirror images, which deepened the mystery: if ordinary chemistry produced no bias, where did life's one-sidedness come from?

The laureates answered with chemistry rather than biology. They showed that a small, almost accidental excess of one form can snowball into near-total dominance, offering a plausible chemical route from a mixed starting point to the homochiral chemistry that underpins every cell. For the Nobel committee, awarding the Chemistry Nobel for homochirality was a nod to how basic research can sit quietly for decades before its full value is clear. The insight reaches beyond drug factories. It gives researchers a working model for how the first single-handed molecules could have appeared on the early Earth, a question tied directly to the origin of life.

The Academy's popular account of the prize put the practical point plainly: once chemists can reliably make a single mirror image, they can design molecules that interact with living things in exactly the intended way. Holden Thorp, editor-in-chief of the journal Science, told reporters that untangling molecular mirror images helps scientists understand the chemical architecture of life.

The human side of the announcement

Soai was out shopping near his home in Japan when the call from Stockholm reached him. In remarks reported by journalists at the announcement, he said he was "very excited" to receive "the very nice news," adding that it was "one of the most exciting days" of his life. He is two decades younger than his co-laureate: Kagan is ninety-five, which makes him the second-oldest recipient of a chemistry Nobel after John B. Goodenough, who was ninety-seven when he received the prize in 2019, according to the Nobel organisation's own account.

This year's Chemistry Nobel arrived in the middle of Nobel week. The award in Physiology or Medicine went to Karl Deisseroth, Peter Hegemann and Georg Nagel for work on optogenetics, a technique that lets researchers switch individual nerve cells on or off with light. Both prizes reward research whose practical consequences have unfolded slowly over decades.

Elsewhere in science this week, Japan's Phobos sample-return mission has drawn attention for what a moon sample could reveal about the early solar system, while research on the octopus genome has shown how biological complexity is written into DNA.

French President Emmanuel Macron congratulated Kagan, calling the prize "an immense source of pride for the country" and a fitting recognition of a lifetime of research, national coverage reported.

Full details of the award and the scientific background are available in the official Chemistry Nobel announcement on nobelprize.org.